D-chiro-Inositol (currently known as INS-1) is a new research drug that is showing promise in the treatment of Polycystic Ovarian Syndrome and mild type II diabetes. It is still in early stages of testing.
News on INS-1
Announcement that Insmed has discontinued its internal development of INS-1, one of its investigational drug candidates for type 2 diabetes and polycystic ovary syndrome (PCOS). (September 10, 2002)
Last update:January 2, 2007 at 16:32:57 UTC